Literature DB >> 12145724

Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples.

Kai Ming Chow1, Viola Chi Ying Chow, Lawrence Cheung Tsui Hung, Shiu Man Wong, Cheuk Chun Szeto.   

Abstract

We identified 60 cases of tuberculous peritonitis during the past 12 years at our health care center. Most of the patients had severe underlying medical conditions, such as cirrhosis, renal failure, diabetes mellitus, and malignancy. Abnormal chest radiograph findings, ascitic fluid lymphocytosis, and biochemical findings for exudates could only identify 33%, 37%, and 53% of the cases, respectively. On the other hand, peritoneal biopsy allowed early definitive diagnosis for 9 patients. Thirty-one patients died, 26 of whom died < or =6 weeks after their initial presentation, often before the result of mycobacterial culture was available. Only 8 patients died of advanced disease after antituberculous therapy was started. Univariate analysis showed that advanced age, underlying diagnosis, and delayed initiation of therapy were associated with higher mortality rates. Standard antituberculous chemotherapy is highly effective. However, conventional microbiologic diagnostic methods are slow and not sensitive enough for establishing a diagnosis of tuberculous peritonitis.

Entities:  

Mesh:

Year:  2002        PMID: 12145724     DOI: 10.1086/341898

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  52 in total

1.  Peritoneal tuberculosis as a cause of ascites in a patient with cirrhosis.

Authors:  Ana Margarida Vaz; Bruno Peixe; Rita Ornelas; Horácio Guerreiro
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Comparison between laparoscopy and noninvasive tests for the diagnosis of tuberculous peritonitis.

Authors:  Kwang Dae Hong; Sun Il Lee; Hong Young Moon
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

3.  [A 67-year-old man with fever, night sweat and ascites].

Authors:  A Hiseni-Kamberi; W-D Maier; K Junker; M Argirov
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

4.  A prospective audit of the use of diagnostic laparoscopy to establish the diagnosis of abdominal tuberculosis.

Authors:  J Islam; D Clarke; S R Thomson; D Wilson; H Dawood
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

5.  Diagnostic dilemma of abdominal tuberculosis in non-HIV patients: an ongoing challenge for physicians.

Authors:  Rustam Khan; Shahab Abid; Wasim Jafri; Zaigham Abbas; Khalid Hameed; Zubair Ahmad
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

6.  Interferon-gamma release assay in the ascites: Early hint for diagnosis of abdominal tuberculosis.

Authors:  R Lorenz; P Würl; G Haerter; G Cammerer; T Barth; S Hausladen; S Stenger; P Kern
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

Review 7.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

8.  Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.

Authors:  Yi-Jun Liao; Chun-Ying Wu; Shou-Wu Lee; Chia-Ling Lee; Sheng-Shun Yang; Chi-Sen Chang; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

9.  Critical ventriculo-peritoneal shunt failure due to peritoneal tuberculosis: Case report and diagnostic suggestions for abdominal pseudocyst.

Authors:  Hajime Takase; Junya Tatezuki; Naoki Ikegaya; Daisuke Yamamoto; Mizuki Hashimoto; Makoto Takagi; Yasuhiko Mochimatsu; Nobutaka Kawahara
Journal:  Surg Neurol Int       Date:  2014-05-15

Review 10.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.